Cefotaxime is a third-generation cephalosporin antibiotic that is used to treat a variety of bacterial infections, including: Lower respiratory tract infections Pelvic inflammatory disease Endocarditis Meningitis Skin and soft tissue infections Bone and joint infections Septicemia Cefotaxime is available as a generic drug and under the brand names Claforan and Keftab. It is administered by injection or infusion. The global market for cefotaxime is expected to grow at a CAGR of 4.5% from 2022 to 2028. The growth of the market is being driven by the increasing incidence of bacterial infections, the rising demand for generic drugs, and the growing popularity of injectable antibiotics. The following are a list of…